York Space Systems heads into its May 14 earnings report with a tightening borrow market, a short base that just reversed a sharp decline, and options traders who have notably calmed down — an unusual mix of signals for a stock up 17% in a month.
The lending market tells the most urgent part of the story. Availability has collapsed to just 0.18% of short interest — roughly one share available for every 550 already borrowed. Every share in the lending pool is effectively lent out. That is not a new condition: availability has been at or near zero since mid-April, and the ORTEX short score has climbed steadily from 64.6 on April 28 to 68.1 now, its highest reading in the current window. Cost to borrow has risen sharply in parallel. CTB was running around 2% in early April, hit 11.2% this week — a five-fold increase in six weeks. The monthly change is over 360%. For a stock that was trading at ordinary borrow rates just weeks ago, that move signals a meaningful squeeze on available supply.
Short interest itself has had a volatile month. SI as a percentage of free float peaked near 10.3% on April 23, then fell sharply — dropping roughly 25% in a single week as the stock rallied — before stabilising and edging back up to 7.9% this week. That recovery is notable: shorts did not fully exit on the squeeze, and the past seven days have seen shares short climb about 7% from the recent trough. Given that availability is essentially exhausted, any further build in short interest will be expensive. Days to cover from the latest FINRA filing is 1.79, which is low, but that figure predates the recent repositioning.
The analyst picture is broadly constructive, though the Street has been trimming targets since last month's earnings. Goldman Sachs raised its target to $31 on April 20 while keeping a Neutral rating — a cautious note from a bellwether that still leaves it below the current price of $32.71. The consensus across four buy-rated analysts sits at a mean target of $36.33, implying about 11% upside from here. Bulls point to contract wins, a growing backlog, and a runway toward positive Adj. EBITDA and operating cash flow later in 2026. Bears note the company's heavy reliance on long-term production contracts that haven't yet converted to meaningful revenue. The EV/EBITDA multiple has compressed about 10% over the past month to just under 20x — which reflects the recent price run and tightening earnings-based expectations in equal measure.
Options positioning offers a mild counterpoint to the borrow-market stress. The put/call ratio is 0.87, slightly below its 20-day mean of 0.91, with a z-score near zero. That is a shift from early-to-mid April, when the PCR was running above 1.0 and reached a 52-week high of 1.46 on April 16. As the stock rallied through late April, defensive positioning in options eased. Options traders are neither euphoric nor alarmed — which, given the extremity of the borrow situation, reads as a lack of urgency on the downside rather than a directional call.
The institutional structure is concentrated. AE Industrial Partners holds 22% of shares, and Dirk Wallinger — believed to be a founder or senior executive — holds a further 8.8%. BlackRock took a new position of 13.99% of shares in January, entering at $34. That purchase, reported at the end of January, involved over 752,000 shares at $34 per share, suggesting the current price of $32.71 sits modestly below their cost basis. With the next earnings event set for May 14, the focus will be on whether management updates 2026 EBITDA guidance and how production contract revenues are progressing — the data points the bear case hinges on most directly.
See the live data behind this article on ORTEX.
Open YSS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
